Intra- and inter-site reproducibility of human brain single-voxel proton MRS at 3 T.


Journal

NMR in biomedicine
ISSN: 1099-1492
Titre abrégé: NMR Biomed
Pays: England
ID NLM: 8915233

Informations de publication

Date de publication:
06 2019
Historique:
received: 04 10 2018
revised: 24 01 2019
accepted: 28 01 2019
pubmed: 20 3 2019
medline: 18 12 2019
entrez: 20 3 2019
Statut: ppublish

Résumé

Clinical trials that involve participants from multiple sites necessitate standardized and reliable quantitative MRI outcomes to detect significant group differences over time. Metabolite concentrations measured by proton MRS ( Five healthy controls were scanned twice within 24 h at six participating 3 T MR sites with large single-voxel PRESS (TE/TR/NSA = 36 ms/4000 ms/56) and anatomical images for voxel positioning and correction of partial volume relaxation. Absolute metabolite concentrations were calculated relative to the T The median intra-site CoVs for the five major metabolite concentrations ([NAA], [tCr], [Glu], [tCho] and [Ins]) were between 2.5 and 5.3%. Inter-site CoVs were also low, with the median CoVs for all metabolites between 3.7 and 6.4%. Metabolite concentrations were robust to small inconsistencies in voxel placement and site was not the driving factor in the variance of the measurement of any metabolite concentration. Between-subject differences accounted for the majority of the concentration variability for creatine, choline and myo-inositol (42-65% of the variance). A large single-voxel

Identifiants

pubmed: 30889311
doi: 10.1002/nbm.4083
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e4083

Subventions

Organisme : Multiple Sclerosis Society of Canada
Pays : International
Organisme : Philips Canada
Pays : International
Organisme : Sanofi-Genzyme Corporation
Pays : International

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Carina Graf (C)

Physics & Astronomy, University of British Columbia, Vancouver, British Columbia, Canada.
International Collaboration on Repair Discoveries (ICORD), Vancouver, British Columbia, Canada.

Erin L MacMillan (EL)

MR Clinical Science, Philips Canada, Markham, Ontario, Canada.
UBC MRI Research Centre, University of British Columbia, Vancouver, British Columbia, Canada.
ImageTech Lab, Simon Fraser University, Surrey, British Columbia, Canada.

Eric Fu (E)

Statistics, University of British Columbia, Vancouver, British Columbia, Canada.

Trudy Harris (T)

UBC MRI Research Centre, University of British Columbia, Vancouver, British Columbia, Canada.
Radiology, University of British Columbia, Vancouver, British Columbia, Canada.

Anthony Traboulsee (A)

Medicine (Neurology), University of British Columbia, Vancouver, British Columbia, Canada.

Irene M Vavasour (IM)

UBC MRI Research Centre, University of British Columbia, Vancouver, British Columbia, Canada.
Radiology, University of British Columbia, Vancouver, British Columbia, Canada.

Alex L MacKay (AL)

Physics & Astronomy, University of British Columbia, Vancouver, British Columbia, Canada.
UBC MRI Research Centre, University of British Columbia, Vancouver, British Columbia, Canada.
Radiology, University of British Columbia, Vancouver, British Columbia, Canada.

Burkhard Mädler (B)

Philips GmbH, Hamburg, Germany.

David K B Li (DKB)

UBC MRI Research Centre, University of British Columbia, Vancouver, British Columbia, Canada.
Radiology, University of British Columbia, Vancouver, British Columbia, Canada.
Medicine (Neurology), University of British Columbia, Vancouver, British Columbia, Canada.

Cornelia Laule (C)

Physics & Astronomy, University of British Columbia, Vancouver, British Columbia, Canada.
International Collaboration on Repair Discoveries (ICORD), Vancouver, British Columbia, Canada.
Radiology, University of British Columbia, Vancouver, British Columbia, Canada.
Pathology & Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH